Entering text into the input field will update the search result below

Jazz Pharma wins Health Canada approval for Sunosi targeting sleeping disorder

Aug. 31, 2021 9:37 AM ETJazz Pharmaceuticals plc (JAZZ) StockBy: Dulan Lokuwithana, SA News Editor
  • Jazz Pharmaceuticals (NASDAQ:JAZZ) announced the Health Canada approval and commercial availability of Sunosi (solriamfetol) for adults with excessive daytime sleepiness (EDS) linked to narcolepsy or obstructive sleep apnea (OSA).
  • The approval was based on data from the Treatment of Obstructive Sleep

Recommended For You

More Trending News

About JAZZ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
JAZZ--
Jazz Pharmaceuticals plc